Financial Performance - For the fiscal year ending March 31, 2024, the total revenue was HKD 285,204,000, a decrease of 18.1% compared to HKD 348,271,000 in the previous year[2] - The gross profit for the same period was HKD 11,655,000, significantly improved from HKD 110 in the previous year[2] - The loss before tax increased to HKD 275,502,000, compared to a loss of HKD 224,636,000 in the prior year, reflecting a deterioration of 22.6%[3] - The total comprehensive loss for the year was HKD 351,771,000, down from HKD 575,808,000 in the previous year, indicating a 38.9% improvement[3] - The company reported a net loss attributable to owners of the company of HKD 197,262,000, compared to HKD 238,873,000 in the previous year, reflecting a 17.4% improvement[5] - The company reported a loss attributable to owners of the company of HKD 118,640,000 for the year ended March 31, 2024, compared to a loss of HKD 223,615,000 for the previous year[54] - The net loss for fiscal year 2024 was approximately HKD 283.1 million, a decrease of about HKD 244.5 million from HKD 527.6 million in fiscal year 2023[95] Assets and Liabilities - The company's total assets decreased to HKD 1,300,167,000 from HKD 2,416,217,000, a decline of 46.1% year-over-year[7] - Current liabilities exceeded current assets by HKD 1,056,099,000, compared to a surplus of HKD 44,212,000 in the previous year[8] - The company had cash and cash equivalents of HKD 469,000, a significant decrease from HKD 40,638,000 in the previous year[7] - The company’s borrowings amounted to HKD 842,175,000, with a substantial portion classified as current liabilities due to covenant breaches[11] - As of March 31, 2024, the group's net current liabilities were approximately HKD 1,056.1 million, compared to a net current asset of approximately HKD 44.2 million as of March 31, 2023[105] - The group's net liabilities are approximately HKD 332,903,000 respectively, indicating significant uncertainty regarding the group's ability to continue as a going concern[129] Revenue Sources - For the fiscal year ending March 31, 2024, the revenue from property sales was HKD 285,005 thousand, an increase from HKD 169,481 thousand in the previous year, representing a growth of 68.3%[32] - The revenue from construction material sales was HKD 178,637 thousand in the fiscal year ending March 31, 2023, while there was no revenue reported for the fiscal year ending March 31, 2024[32] - The total revenue from continuous operations for the fiscal year ending March 31, 2024, was HKD 285,204 thousand, down from HKD 348,271 thousand in the previous year, indicating a decrease of 18.1%[32] Operational Changes - The company has focused its operations on property development following the sale of its wellness resort business, which is now classified as discontinued operations[24] - The company agreed to sell its wellness resort in Shanghai for a cash consideration of RMB 1,185,000,000 (approximately HKD 1,356,519,000) on November 25, 2022[41] - The company completed the construction of the Yangzhong project, generating revenue of approximately HKD 285.2 million from the sale of 343 apartments with a total construction area of about 42,603 square meters[79] Financing and Liquidity - The group plans to actively negotiate with investors and banks for new financing and to extend bank loan agreements to manage its financial obligations[16] - The group is facing significant uncertainty regarding its ability to continue as a going concern due to the inability to recover loans totaling RMB 135.0 million (equivalent to HKD 146.3 million) from Bao Ji Holdings[14] - The group has a bank balance of approximately HKD 14.9 million that has been frozen due to legal claims amounting to RMB 41.5 million (equivalent to HKD 45.0 million)[12] - The group continues to sell completed properties and pre-sell development properties to increase liquidity[109] Legal and Compliance Issues - The group faces several legal claims primarily related to construction contract disputes in its property development projects[113] - The independent auditor's report states that no opinion is expressed on the consolidated financial statements due to insufficient appropriate audit evidence[128] - The audit committee has critically reviewed the basis for the disclaimer of opinion and acknowledges the management's view on the group's ability to continue operating[133] Future Outlook - The company anticipates that the real estate industry will continue to face structural adjustments and challenges in the upcoming fiscal year 2025[96] - The group plans to focus on the biopharmaceutical and medical device industry parks, establishing a comprehensive development strategy starting in 2023[100] - The group anticipates challenges in its existing industrial park development model by 2025, necessitating a strategic upgrade[99]

Financial Performance - For the six months ended September 30, 2023, the company reported revenue of HK$274,659,000, a slight increase of 2.4% compared to HK$268,047,000 for the same period in 2022[11]. - The gross profit for the same period was HK$12,114,000, up from HK$11,573,000, reflecting a gross margin improvement[11]. - The loss before tax decreased to HK$18,548,000 from HK$23,911,000, indicating a reduction in operational losses[11]. - The total comprehensive income for the period was a loss of HK$45,762,000, compared to a loss of HK$184,815,000 in the previous year, showing significant improvement[15]. - The company incurred a loss for the period from continuing operations of HK$23,211,000, down from HK$28,457,000 in the prior year[11]. - Total comprehensive income attributable to owners of the company for the six months ended September 30, 2023, was a loss of HK$34,584,000, compared to a profit of HK$55,008,000 in the same period of 2022[16]. - Loss per share attributable to owners of the company for continuing operations was HK$0.59 cent, down from HK$2.09 cent in the previous year[16]. - The adjusted loss before tax for the group was HK$18,548,000, compared to a much larger loss of HK$123,573,000 in the previous year[60][65]. - The net loss for the six months ended 30 September 2023 was approximately HK$23.2 million, a significant improvement from a net loss of approximately HK$128.1 million in the same period of 2022[140][142]. Operational Costs - Administrative and other expenses increased to HK$22,730,000 from HK$14,871,000, indicating rising operational costs[11]. - The Group's cash used in operations increased significantly from HK$14,603,000 to HK$45,926,000 year-over-year[27]. - Employee benefit expenses, excluding directors' remuneration, were HK$7,850,000, slightly down from HK$7,874,000, showing a marginal decrease of 0.3%[77]. - The provision for current PRC Land Appreciation Tax (LAT) was HK$4,764,000, compared to HK$2,664,000 in the prior year, marking an increase of approximately 78.3%[84]. Asset and Liability Management - Total non-current assets decreased to HK$739,241,000 as of September 30, 2023, from HK$772,260,000 as of March 31, 2023[20]. - Current assets decreased significantly to HK$686,894,000 from HK$1,643,957,000 over the same period[20]. - Total current liabilities decreased to HK$609,101,000 from HK$1,599,745,000, indicating improved liquidity management[20]. - Net current assets increased to HK$77,793,000 from HK$44,212,000, reflecting a positive shift in short-term financial health[21]. - Non-current liabilities decreased to HK$753,998,000 from HK$807,674,000, showing a reduction in long-term debt obligations[21]. - Equity attributable to owners of the company improved to HK$(70,162,000) from HK$(135,578,000), indicating a recovery in shareholder equity[21]. - The Group's total borrowings as of September 30, 2023 amounted to HK$826,659,000, a decrease from HK$1,147,116,000 as of March 31, 2023[117]. - The gearing ratio of the Group was 13.4 times as of September 30, 2023, a significant decrease from 133.1 times as of March 31, 2023[198]. Investment and Strategic Focus - The Group continues to focus on property development and management services as its primary business strategy moving forward[6]. - The healthcare holiday resort in Shanghai was sold for RMB1,185,000,000 (approximately HK$1,356,519,000), which is a strategic divestment aimed at focusing on core operations[86]. - The Group anticipates challenges in its original property development model in 2024 and plans to upgrade its industrial development strategy focusing on the health industry[176]. - The strategic focus will shift towards investment and operational services in the biopharmaceutical and medical device industry parks starting in 2023[177]. - The Group plans to establish new integrated industrial zones for biomedical and medical devices in the Yangtze River Delta region, replicating the successful experience of Boill e-Pharmaceutical Valley[187]. Cash Flow and Financing - The Group's cash and cash equivalents at the end of the period were approximately HK$24,207,000[30]. - During the same period, cash used in operating activities was HK$46,627,000, compared to cash generated of HK$55,416,000 in the previous year[27]. - The Group generated net cash flows from investing activities of HK$463,496,000, compared to a cash outflow of HK$68,380,000 in the prior year[27]. - A capital contribution of HK$100,000,000 was made by a substantial shareholder through a debt waiver agreement[26]. - The Group's cash and cash equivalents were approximately HK$24,207,000 as of 30 September 2023, indicating a potential liquidity issue[31]. Market and Future Outlook - The company is focusing on enhancing its operational efficiency and exploring new market opportunities to drive future growth[15]. - The Group's operations are segmented into property development and discontinued operations related to the healthcare resort, with the latter no longer reported separately[47]. - Management expects to receive remaining proceeds of RMB79,213,000 (approximately HK$85,014,000) from the disposal of the healthcare holiday resort in Shanghai on time[37]. - The Group plans to cooperate with domestic and foreign biomedical and medical device professional investment funds for strategic investments in enterprises within the zones[189].

香港交易及結算所有限公司以及香港聯合交易所有限公司對本公告之內容概不負責,對 其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內 容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 | Boill Healthcare Holdings Limited | |-------------------------------------------------| | 保 集 健 康 控 股 有 限 公 司 | | (於開曼群島註冊成立之有限公司) | | (股份代號: 1246 ) | | 截至二零二三年九月三十日止六個月之 | | 中期業績公告 | 保集健康控股有限公司(「本公司」)之董事(「董事」)會(「董事會」)公佈本公司及其附屬公 司(統稱為「本集團」)截至二零二三年九月三十日止六個月之未經審核業績連同二零二二 年同期之比較數字,載列如下。未經審核簡明綜合中期財務資料已由本公司之審核委員 會(「審核委員會」)審閱。 簡明綜合損益及其他全面收益表 | | | 截至九月三十日止六個月 | | |----------------------------|------|------- ...

Financial Performance - The Group's revenue for FY2023 was approximately HK$355.4 million, a decrease of approximately HK$660.8 million or 65.0% from HK$1,016.2 million in FY2022[14]. - Revenue from property development for FY2023 was approximately HK$348.3 million, down from approximately HK$1,004.6 million in FY2022[14]. - The loss attributable to owners of the Company for FY2023 was approximately HK$428.3 million, compared to HK$517.8 million in FY2022[15]. - Basic and diluted loss per share for FY2023 was approximately HK31.54 cents, compared to HK38.13 cents in FY2022[15]. - The gross profit for FY2023 was approximately HK$0.1 million, representing a decrease of approximately HK$109.4 million or 99.9% from FY2022's gross profit of approximately HK$109.5 million[42][47]. - Other income and gains for FY2023 were approximately HK$1.0 million, compared to a loss of approximately HK$0.5 million in FY2022, mainly due to government subsidies and bank interest income[44][48]. - Selling and distribution expenses decreased from approximately HK$14.6 million in FY2022 to approximately HK$7.7 million in FY2023, attributed to reduced advertising and marketing costs[45][49]. - Administrative and other expenses for FY2023 were approximately HK$22.3 million, a decrease of approximately HK$10.1 million from approximately HK$32.4 million in FY2022[51][53]. - Financial costs for FY2023 were approximately HK$43.5 million, a decrease of approximately HK$4.6 million from approximately HK$48.1 million in FY2022[58]. - Income tax expense for FY2023 was approximately HK$2.0 million, down from approximately HK$8.9 million in FY2022, primarily due to reduced gross profit[59]. - The net loss for FY2023 was approximately HK$527.6 million, a decrease of approximately HK$228.1 million from HK$755.7 million in FY2022[70]. Development Projects - The Group acquired land use rights for a plot of approximately 63,481 square meters in Fengxian District, PRC, for future development[16]. - The planned development includes 30 buildings with a total estimated gross floor area of approximately 160,090 square meters, expected to be completed by April 2024[17]. - The integrated industrial zone aims to attract businesses in medical equipment, biomedical, and medical beauty industries[17]. - The construction on the land commenced in September 2021[17]. - The Yangzhong Project recorded revenue of approximately HK$169.5 million from the sales of 159 apartments in FY2023, with a total gross floor area of approximately 19,407 square meters[31]. - The Group plans to implement a "two-wheel driven strategy" focusing on biomedical and medical equipment industrial zones, enhancing investment and operational services[20][21]. - The Park aims to integrate advantageous resources in Shanghai, focusing on innovative medicines and medical devices, creating an intelligent healthcare industrial park[21]. - The Park will enhance its capabilities in resource integration, service construction, and platform building, forming six core competencies[21]. - The Group aims to establish integrated industrial zones for biomedical and medical devices in the Yangtze River Delta region, replicating successful experiences from existing projects[83]. ESG and Sustainability - The Group presented its Environmental, Social and Governance (ESG) Report for the year ended March 31, 2023, in accordance with the ESG Reporting Guide under the Listing Rules[163]. - The past year was marked by significant regulatory reforms, heightened geopolitical tensions, and the impact of the COVID-19 pandemic on the economy and society[164]. - The Group reinforced sustainable development principles across all business lines by enhancing ESG internal controls and strengthening corporate governance[164]. - Management prioritized employee safety during the pandemic, implementing sufficient protection measures across different business divisions[165]. - The Group's commitment to ESG risk management focused on key areas such as COVID-19 and climate change[164]. - The Group has implemented measures to manage climate-related risks, contributing to the net-zero economy goals of China and Hong Kong[166]. - A green environmental strategy has been devised that spans across all business segments, allowing the Group to measure the effectiveness of current environmental policies[166]. - The Group will focus on green environmental strategies, protection of staff from COVID-19, and new ESG opportunities moving forward[169]. - Major concerns of stakeholders include profitability, financial stability, and information disclosure and transparency[175]. - The Group disclosed quantitative indicators in the "environment" category in accordance with the ESG Reporting Guide, with plans for full disclosure in the "society" category in the future[177]. - Material ESG issues identified include carbon emissions, electricity and water consumption, and workplace health and safety[184]. - The Group welcomes stakeholder feedback on its ESG approach and performance through various communication channels[186]. Management and Governance - The company has a strong management team with diverse backgrounds in finance and investment, enhancing its strategic development capabilities[139][140][147][150]. - The company is focused on strategic development and business management, with a structured reporting system to the board[139]. - The management team has experience in project investment and asset restructuring, which is crucial for future growth initiatives[147]. - The company is committed to maintaining high standards of corporate governance through its board composition[150]. - The diverse expertise of the board members positions the company well for navigating market challenges and opportunities[140][147][150]. - The Group's financial controller and company secretary has over 12 years of experience in auditing, accounting, and financial management[158]. Financial Position - As of March 31, 2023, the Group's interest-bearing borrowings amounted to approximately HK$1,147.1 million, a decrease from approximately HK$1,541.0 million as of March 31, 2022[91]. - The Group's net current assets as of March 31, 2023, were approximately HK$44.2 million, a significant improvement from net current liabilities of approximately HK$1,056.7 million as of March 31, 2022[95]. - The gearing ratio of the Group as of March 31, 2023, was 133.1 times, compared to 623.1% as of March 31, 2022[96]. - The Group's cash and bank deposits (excluding restricted deposits) as of March 31, 2023, were approximately HK$40.6 million, down from approximately HK$46.5 million as of March 31, 2022[95]. - The Group's borrowings of approximately HK$365.9 million as of March 31, 2023, were repayable within one year, bearing interest at fixed rates ranging from 5% to 15% per annum[93]. - The Group has no significant capital commitments as of March 31, 2023[100]. - The Group did not engage in any hedging activities during the fiscal year 2023, and there are no plans for hedging in the near future[99]. - The Group's assets and cash flows were primarily denominated in RMB, while a significant portion of interest-bearing borrowings was in US dollars, leading to foreign exchange risk[106]. Employee and Operational Insights - The Group's total employee costs from continuing operations for FY2023 amounted to approximately HK$16.8 million, a decrease from approximately HK$20.6 million in FY2022[115]. - The Group's employee count stood at 97 as of 31 March 2023, with 90 employees in China and 7 in Hong Kong[115]. - The Group did not recommend the payment of a final dividend for FY2023, consistent with FY2022 where no dividend was paid[118]. - There were no material acquisitions or disposals of subsidiaries, associates, or joint ventures during FY2023, except for a disposal[109].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其 準確性或完整性亦不發表任何聲明,並明確表示,概不就因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 截至二零二三年三月三十一日止年度之全年業績公告 保集健康控股有限公司(「本公司」)之董事會(「董事會」或「董事」)謹此公佈本公司及其附 屬公司(統稱為「本集團」)截至二零二三年三月三十一日止年度之經審核綜合業績連同去 年同期經審核比較數字及相關解釋附註,載列如下: 綜合損益及其他全面收益表 截至二零二三年三月三十一日止年度 | | | 二零二三年 | 二零二二年 | |--------------------------------------------|------|----------------|--------------| | | 附註 | 千港元 | 千港元 | | | | | (經重列) | | 持續經營業務 | | | | | 收益 | 5 | 348,271 | 1,004,596 | | 銷售成本 | | (348,161) | (895,093) | | 毛利 | | 110 | ...

Financial Performance - Revenue for the six months ended September 30, 2022, was HK$271,648,000, a decrease of 67.7% compared to HK$842,276,000 for the same period in 2021[18]. - Gross profit for the same period was HK$9,801,000, down 87.7% from HK$79,565,000 in 2021[18]. - Loss before tax for the period was HK$123,573,000, compared to a loss of HK$21,752,000 in the previous year, indicating a significant increase in losses[18]. - The total comprehensive income for the period was HK$184,815,000, compared to a loss of HK$3,507,000 in the same period last year[22]. - Basic and diluted loss per share attributable to owners of the company was HK7.07 cents, compared to HK0.72 cents in 2021[22]. - The adjusted loss before tax for the Group was HK$123,573,000, reflecting significant financial costs of HK$58,052,000[49]. - The net loss for the same period was approximately HK$128.1 million, compared to a net loss of approximately HK$27.1 million in 2021, with a basic and diluted loss per share of approximately HK$7.07 cents[172][174]. - The significant increase in net loss was primarily due to fair value loss on investment properties and impairment loss on property, plant, and equipment, attributed to the Pandemic's adverse impact and weakened demand from potential home-buying customers[192]. Assets and Liabilities - As of September 30, 2022, total non-current assets decreased to HK$1,864,624, down 9.9% from HK$2,069,008 as of March 31, 2022[23]. - Current assets totaled HK$1,248,006, a decrease of 12.4% from HK$1,425,744 as of March 31, 2022[23]. - Total current liabilities amounted to HK$2,282,625, down 8.0% from HK$2,482,471 as of March 31, 2022[23]. - The net current liabilities were recorded at (HK$1,034,619), slightly improved from (HK$1,056,727) as of March 31, 2022[26]. - Total equity decreased to HK$66,354, down from HK$251,169 as of March 31, 2022, indicating a significant decline in net assets[26]. - Total liabilities as of 30 September 2022 were HK$3,046,276,000, compared to HK$3,243,583,000 as of 31 March 2022, indicating a reduction in liabilities[105]. - Total borrowings as of September 30, 2022, were HK$1,491,340,000, slightly down from HK$1,541,006,000 as of March 31, 2022, indicating a decrease of about 3.2%[150]. Cash Flow - Cash generated from operations was HK$56,702,000, compared to a cash used in operations of HK$42,498,000 in the previous year[31]. - Net cash flows from operating activities amounted to HK$55,416,000, a significant improvement from a net cash outflow of HK$46,476,000 in the same period last year[31]. - The Group's cash and cash equivalents at the end of the period were HK$35,458,000, down from HK$120,597,000 at the end of the previous year[31]. - The Group anticipates sufficient working capital to finance operations and meet financial obligations in the foreseeable future[33]. - The Group's cash flow projections indicate the ability to continue as a going concern, despite the material uncertainty regarding its ability to realize assets and discharge liabilities[33]. Investment Properties - Fair value loss on investment properties was HK$33,759,000, compared to a gain of HK$3,494,000 in the previous year[18]. - The Group incurred a fair value loss on investment properties amounting to HK$33,759,000 during the reporting period[49]. - As of 30 September 2022, the Group's investment properties had a carrying amount of HK$1,448,254,000, down from HK$1,582,690,000 as of 31 March 2022[131]. - The Group's investment properties are intended to be held for rental income or capital appreciation purposes[131]. Segment Performance - Segment results showed a loss of HK$71,994,000, with property development and healthcare holiday resort development reporting losses of HK$6,935,000 and HK$64,651,000 respectively[48]. - The Group's foundation piling segment did not contribute any revenue for the six months ended 30 September 2022 due to intense market competition and the adverse impact of the pandemic[181]. - The management monitors segment performance based on adjusted profit/loss before tax, excluding interest income and finance costs[44]. Operational Challenges and Future Outlook - The management expects 2023 to be a challenging year due to pressures from external financing and internal operating cash flow in the real estate sector[194]. - The Group aims to develop integrated industrial zones focusing on biomedicine and artificial intelligence, leveraging resources from its substantial shareholder, Boill Holding[194]. - The foundation piling business is expected to continue suffering losses in the short to medium term due to the Pandemic and intense market competition[200]. - The Board will continue to review the foundation piling business and explore opportunities to minimize losses[200]. - The economic recovery prospects remain uncertain, impacting the Group's financial results and development plans[194].

Financial Performance - For the fiscal year ended March 31, 2022, the company reported total revenue of HKD 1,016,162,000, a significant increase from HKD 216,710,000 in the previous year, representing a growth of approximately 369%[1] - The gross profit for the same period was HKD 108,422,000, compared to HKD 18,971,000 in the prior year, indicating a substantial increase in profitability[1] - The company incurred a net loss of HKD 755,735,000 for the year, a significant increase from a net loss of HKD 175,490,000 in the previous year, reflecting a deterioration in financial performance[1] - The total comprehensive loss for the year amounted to HKD 714,187,000, compared to a comprehensive loss of HKD 56,912,000 in the previous year, highlighting ongoing challenges[3] - The company reported a significant increase in revenue from property development, with HKD 1,004,596,000 generated in the year ended March 31, 2022, compared to HKD 204,342,000 in the previous year[39]. - The company experienced a pre-tax loss of HKD 744,781,000 for the year ended March 31, 2022, compared to a pre-tax loss of HKD 180,629,000 for the previous year[36]. - The net loss for fiscal year 2022 was approximately HKD 755.7 million, a significant increase from HKD 175.5 million in fiscal year 2021, primarily due to fair value losses on investment properties and impairment losses[91] Assets and Liabilities - The company's total non-current assets as of March 31, 2022, were valued at HKD 2,069,008,000, slightly down from HKD 2,107,432,000 a year earlier[5] - Current assets decreased to HKD 1,425,744,000 from HKD 1,660,927,000, indicating a reduction in liquidity[5] - Total current liabilities were reported at HKD 2,482,471,000, down from HKD 2,798,898,000, suggesting improved management of short-term obligations[7] - The company's net asset value decreased to HKD 251,169,000 from HKD 953,023,000, reflecting a significant decline in equity[7] - Total assets amounted to HKD 3,494,752,000 as of March 31, 2022, compared to HKD 3,768,359,000 as of March 31, 2021[36]. - The company reported total liabilities of HKD 3,243,583,000 as of March 31, 2022, compared to HKD 2,815,336,000 as of March 31, 2021[36]. - The group’s net current liabilities were approximately HKD 1,056.7 million as of March 31, 2022, compared to approximately HKD 1,138.0 million as of March 31, 2021[101] - The group has a total borrowing of HKD 1,541,006,000, with secured loans ranging from 4.1% to 15% interest rates[67] Shareholder and Investment Information - Basic and diluted loss per share for the year was HKD 38.13, compared to HKD 12.70 in the previous year, indicating a worsening loss per share[3] - Major shareholders have agreed not to demand repayment of HKD 754,632,000 until the group is able to repay[10] - The group is actively seeking potential investors interested in co-developing or purchasing projects[12] - The group has issued 1,358,000,000 shares with a paid-up capital of HKD 339,500,000 as of March 31, 2022[69] Operational Segments - The group operates in four main segments: property development, wellness resort development and operation, foundation piling, and securities investment[32] - The group’s foundation piling division did not contribute any revenue in the fiscal year 2022, compared to approximately HKD 0.6 million in the previous fiscal year[77] Expenses and Costs - The company incurred administrative and other expenses of HKD 59,666,000 for the year ended March 31, 2022, down from HKD 69,702,000 in the previous year[42]. - Selling and distribution expenses increased from approximately HKD 15.7 million in fiscal year 2021 to about HKD 19.4 million in fiscal year 2022, driven by increased advertising and marketing personnel costs[86] - Interest expenses from borrowings and contract liabilities increased to HKD 264,465,000 in 2022 from HKD 182,132,000 in 2021, representing a growth of 45.1%[48] - The cost of properties sold surged to HKD 893,551,000 in 2022 compared to HKD 184,738,000 in 2021, marking an increase of 384.5%[48] Tax and Compliance - The total tax expense for the year was HKD 10,954,000 in 2022, compared to a tax credit of HKD 5,139,000 in 2021[51] - The company has confirmed compliance with the corporate governance code throughout the fiscal year 2022, except for deviation from code provision A.2.1 regarding the separation of roles between the chairman and CEO[119] - All directors have confirmed compliance with the standard code of conduct for securities trading throughout the fiscal year 2022[120] Future Plans and Developments - The group plans to develop a comprehensive industrial park with an estimated total construction area of approximately 160,090 square meters, expected to be completed by April 2024[74] - The company plans to develop integrated industrial parks focusing on biomedicine and artificial intelligence, leveraging resources from its major shareholder[94] - The company aims to enhance its operational service capabilities in integrated industrial parks and develop light asset service businesses[95] Audit and Reporting - The audit committee has reviewed the unaudited consolidated financial statements for the fiscal year 2022 and discussed accounting policies, risk management, and internal control systems with senior management[124] - Due to COVID-19 restrictions, the completion of the audit process was delayed, affecting the timeline for the audited financial statements for the year ending March 31, 2022[125] - The company plans to publish further announcements regarding the audited financial results and adjustments after the completion of the audit process, expected by July 29, 2022[126]

Financial Performance - Revenue for the six months ended September 30, 2021, was HK$842,276,000, a significant increase from HK$19,636,000 in the same period of 2020, representing a growth of approximately 4,287%[21] - Gross profit for the same period was HK$79,565,000, compared to a gross loss of HK$4,329,000 in 2020, indicating a turnaround in profitability[21] - Loss for the period was HK$27,128,000, an improvement from a loss of HK$80,070,000 in the previous year, reflecting a reduction in losses by approximately 66%[21] - Total comprehensive income for the period was (3,507) thousand HKD, compared to (22,282) thousand HKD in the previous year, indicating a significant improvement[25] - Loss attributable to owners of the company was (9,765) thousand HKD, a reduction from (71,197) thousand HKD year-on-year[25] - The company reported a loss of approximately HK$27,128,000 for the six months ended September 30, 2021[38] - The Group's net loss for the six months ended 30 September 2021 was approximately HK$27.1 million, a significant improvement compared to a net loss of approximately HK$80.1 million for the same period in 2020[148] Expenses and Costs - Finance costs increased to HK$61,674,000 from HK$45,466,000, representing a rise of about 36% year-over-year[21] - Selling and distribution expenses were HK$9,854,000, up from HK$4,183,000, indicating increased investment in sales efforts[21] - Administrative and other expenses slightly decreased to HK$30,402,000 from HK$30,937,000, showing cost control measures[21] - The total loss before tax for the group was HK$21,752,000, with finance costs amounting to HK$61,674,000[52] - Employee benefit expenses, including directors' remuneration, totaled HK$14,826,000 in wages and salaries for the six months ended September 30, 2021[87] - The income tax expense for the six months ended 30 September 2021 was approximately HK$5.4 million, compared to an income tax credit of approximately HK$4.8 million for the same period in 2020[148] Assets and Liabilities - Total non-current assets increased to 2,260,521 thousand HKD from 2,107,432 thousand HKD, reflecting a growth of approximately 7.25%[27] - Current assets decreased to 1,247,527 thousand HKD from 1,660,927 thousand HKD, a decline of about 25%[27] - Total current liabilities decreased to 2,549,760 thousand HKD from 2,798,898 thousand HKD, showing a reduction of approximately 8.9%[27] - Net current liabilities stood at (1,302,233) thousand HKD, compared to (1,137,971) thousand HKD in the previous period[30] - Total assets as of September 30, 2021, amounted to HK$3,508,048,000[57] - Total liabilities reached HK$2,558,532,000, with borrowings accounting for HK$940,432,000[57] Cash Flow - Cash flows from operating activities showed a net outflow of HK$46,476,000 for the six months ended September 30, 2021[36] - Cash flows from investing activities resulted in a net outflow of HK$124,831,000 during the same period[36] - Financing activities generated net cash inflows of HK$165,186,000 for the six months ended September 30, 2021[36] - Cash and cash equivalents at the end of the period were HK$120,597,000[36] Market and Business Strategy - The company aims to continue expanding its market presence and enhancing product offerings in the upcoming periods[21] - The Group aims to accelerate the construction and pre-sale of properties under development and completed properties held for sale in the People's Republic of China[41] - The Group plans to explore different financing channels to reduce financial costs and improve the revenue and profitability of its healthcare holiday resort development and operation business[148] - The Group continues to focus on residential and industrial property development as its main business[138] - The long-term outlook for the economy and property market in the PRC remains optimistic despite the pandemic's impact[148] Shareholder Information - Basic and diluted loss per share attributable to owners of the company was 0.72 HKD cents, down from 7.85 HKD cents in the previous year[25] - The weighted average number of ordinary shares in issue during the period was 1,358,000,000, compared to 907,400,000 in 2020[99] - The total number of issued shares of the Company was 1,358,000,000 ordinary shares, each with a par value of HK$0.25[194] Corporate Governance - The company has complied with all provisions of the Corporate Governance Code throughout the six months ended September 30, 2021, except for the separation of the roles of chairman and chief executive officer[198] - Mr. Dai Dong Xing serves as both chairman and an executive director, with no position titled "Chief Executive Officer" currently in place[198] - All directors confirmed compliance with the Model Code for securities transactions throughout the six months ended September 30, 2021[198]

Financial Performance - The Group's revenue for FY2021 was approximately HK$216.7 million, an increase of approximately HK$110.3 million or 103.7% compared to FY2020 revenue of approximately HK$106.4 million[12]. - The Group recorded a net loss of approximately HK$175.5 million for FY2021, an improvement from a net loss of approximately HK$223.8 million in FY2020[12]. - Basic loss per share for FY2021 was HK$12.70 cents, compared to HK$20.88 cents in FY2020 (restated)[12]. - The Group recorded revenue of approximately HK$201.5 million for FY2021, representing an increase of 112.8% compared to FY2020[28]. - Revenue from the property development business increased by approximately HK$107.0 million for FY2021, representing an increase of approximately 110.0% over FY2020[34]. - The gross profit for FY2021 was approximately HK$19.0 million, an increase of approximately HK$8.2 million or 75.9% compared to FY2020's gross profit of approximately HK$10.8 million[34]. - Other income and gains for FY2021 were approximately HK$9.9 million, a turnaround from a loss of approximately HK$0.8 million in FY2020, mainly due to a gain on bargain purchase of approximately HK$6.1 million[37]. - Selling and distribution expenses increased from approximately HK$7.1 million in FY2020 to approximately HK$15.7 million in FY2021, primarily due to increased advertising costs and sales staff expenses[37]. - Administrative and other expenses for FY2021 were approximately HK$69.7 million, an increase of approximately HK$19.8 million over FY2020, mainly due to increased depreciation and professional fees related to acquisitions[37]. - Finance costs for FY2021 were approximately HK$122.6 million, an increase of approximately HK$38.9 million from approximately HK$83.7 million in FY2020, attributed to a rise in the weighted average interest rate of borrowings[40]. Property Development - The Group expanded its property development business in October 2020 after acquiring Set Flourish Ventures Limited, which operates the Yangzhong Project[13]. - The Yangzhong Project is located at No. 1 Yihe Road, with a total site area of approximately 53,339.83 square meters, designated for residential and commercial use[13]. - The Yangzhong Project has started generating revenue during FY2021[13]. - Revenue increase primarily driven by sales from the Yangzhong Project acquired during FY2021 and the Shanghai Project, which commenced operations in November 2019[16]. - The Group's property sales under the Yueyang Project launched in 2017 were sold out during FY2021[25]. - The Group plans to construct 12 buildings under the Yangzhong Project with an estimated total gross floor area of approximately 173,457 square meters[25]. - The Yangzhong Project has a total site area of approximately 53,339.83 square meters, with land use rights granted for residential and commercial purposes[25]. - The Shanghai Project has a total site area of approximately 150,602 square meters and a total gross floor area of approximately 77,213 square meters, with rental and service fee income expected to improve significantly as operations in Mainland China resume[28]. - The construction of the first two phases of the Shanghai Project has been completed, with leasable units rented out since November 2019[28]. - The third phase of the Shanghai Project is currently in the review stage of development planning[28]. Strategic Initiatives - The Group has formulated long-term growth strategies around the 3+X model, focusing on health real estate, health services, and health products, with X representing health smart business based on big data[16]. - The Group anticipates continued demand for wellbeing-related goods and services due to the steady growth of China's economy and increasing household income[16]. - The Group aims to cooperate with leading companies in the medical and healthcare field to build new business growth segments[16]. - The Group's strategy includes sustainable expansion in high-end real estate and living services, leveraging opportunities in the healthcare sector[16]. - The Group plans to explore different financing channels to acquire land reserves or property development companies to improve the revenue and profitability of its healthcare holiday resort development and operation business[40]. - The long-term outlook for the Chinese economy remains optimistic, with the central government expected to maintain stability in the property market and implement city-specific measures to regulate short-term overheating in real estate investment[40]. - The Group aims to enhance profitability and strengthen market competitiveness through business expansion in potential cities and product innovation[43]. - The pandemic has increased demand for wellbeing-related goods and services, providing opportunities for the Group's sustainable expansion in healthcare holiday resort development[43]. - The Group has formulated a long-term growth strategy focusing on high-quality real estate and the development of properties in tourism, vacation, regimen culture, and healthcare[43]. Environmental, Social, and Governance (ESG) Initiatives - The Group aims to generate revenue for investors while ensuring compliance with all applicable legislation and reducing waste and pollutants emitted into the environment[94]. - Key ESG issues identified include carbon emissions, electricity and water consumption, and measures to reduce environmental impact, which are critical to the Group's operations[91]. - Stakeholder concerns include profitability, financial stability, information disclosure, and transparency, which are addressed through various communication channels[87]. - The Group is committed to providing a green, healthy, and safe workspace for staff, visitors, and contractors, promoting environmental awareness through training and workshops[94]. - The Group's management emphasizes the importance of minimizing environmental impacts attributable to local operational activities[94]. - The Group's ESG report is prepared in accordance with the Hong Kong Stock Exchange's ESG Reporting Guide, ensuring transparency and accountability[84]. - The Group's initiatives in community investment and corporate social responsibility are aimed at enhancing its relationship with the public and stakeholders[87]. - The Group's focus on employee development and training opportunities reflects its commitment to maintaining a motivated and skilled workforce[91]. - The Group's air emissions for FY2021 included 6 kg of NOx, 1 kg of SOx, and less than 1 kg of PM, showing a significant reduction of 99% for NOx and PM compared to FY2020[104]. - The direct CO2e emissions (Scope 1) decreased by 97% to 71 tonnes in FY2021 from 2,613 tonnes in FY2020[104]. - Indirect CO2e emissions (Scope 2) increased by 1,630% to 571 tonnes in FY2021, compared to the previous year[104]. - The Group's total carbon footprint for the ESG Reporting Year was 648 tonnes CO2e, a 75% reduction from 2,646 tonnes in the previous year[111]. - The reduction in emissions was primarily due to the interruption of construction projects in the wellness resort development segment during the ESG Reporting Year[114]. - The Group has implemented an internal environmental protection awareness program to encourage employees and clients to improve environmental performance[100]. - The Group has taken measures to ensure compliance with relevant environmental laws and regulations in both Hong Kong and the PRC[99]. - The Group's waste management guidelines and procedures are in place to ensure proper handling of all waste generated from operations[115]. - The Group plans to analyze collected data and collaborate with employees and external stakeholders to minimize its carbon footprint[111]. - The Group's environmental initiatives include strict supervision of construction processes and timely applications for government inspections post-project completion[99]. - The Group's total electricity consumption for FY2021 was 679,958 kWh, a decrease of 3% compared to FY2020's 698,652 kWh[127]. - The Group reported zero diesel consumption in FY2021, a 100% reduction from 190,247 liters in FY2020, primarily due to the completion of construction works for phases 1 and 2 of a resort project[127]. - Water consumption decreased by 60% in FY2021, totaling 9,867 m³ compared to 24,618 m³ in FY2020, reflecting the effectiveness of the Group's conservation measures[131]. - The Group implemented energy-saving measures, including adjusting air conditioning to 25.5°C and replacing fluorescent lights with LED systems[126]. - The Group's natural gas consumption increased by 174% to 2,233 m³ in FY2021, while petroleum consumption rose by 502% to 26,492 liters[133]. - The Group collected an estimated 90 m³ of non-hazardous waste in the ESG Reporting Year, down from 108 m³ in the previous year[121]. - The Group has established waste management guidelines to ensure proper treatment of hazardous and non-hazardous waste[118]. - The Group's resource management program focuses on minimizing energy and resource use while promoting recycling and environmental protection[134]. - There were no major accidents reported during the ESG Reporting Year, and the Group complied with all applicable waste-related laws and regulations[131]. - The Group will continue to monitor resource consumption and implement further improvements in energy and water efficiency[134]. - The Group used a total of 0.1 tons of paper during the ESG Reporting Year, the same as the previous reporting year, with a paper consumption intensity of 0.0004 per million Hong Kong dollars of revenue, down from 0.0010 in the previous year[138]. - The Group plans to implement a paperless working environment to reduce paper usage and facilitate information sharing via online networks[138]. Human Resources and Management - The Group had a total of 136 employees as of March 31, 2021, with a total employee remuneration of approximately HK$28,936,000 for the fiscal year[60]. - The Group's remuneration policy ensures fair compensation and continuous learning opportunities for employees, aiming to attract and retain talent[140]. - Employees are entitled to competitive remuneration packages, including performance bonuses, based on market conditions and individual qualifications[145]. - The Group complies with all applicable employment and labor laws, including providing mandatory provident fund and social insurance benefits to employees in Hong Kong and mainland China[146]. - The Group encourages employees to adopt duplex printing and copying, which has become a norm within the organization, contributing to reduced paper consumption[138]. - The Group maintains a focus on non-toxicity and environmental friendliness in sourcing packaging materials for its operations[138]. - The Group's senior management maintains communication with employees to ensure a culture of fairness and equity is implemented throughout the organization[140]. - The Group's workforce age distribution shows that 31% are below 30, 45% are between 31-40, 21% are between 41-50, and 3% are above 50[180]. - Employee gender distribution indicates 42% are female and 58% are male[180]. - The Group has maintained a high occupational safety and health standard, ensuring a safe working environment with no reported injury cases during the ESG Reporting Year[184]. - The Group participates in the MPF scheme, contributing a percentage of employees' basic salaries to the scheme, which is charged to the Group's profit or loss as they become payable[149]. - The Group's subsidiaries in the PRC are required to contribute a specific percentage of their payroll costs to a central pension scheme, depending on their location[149]. - The Group has established a Remuneration Committee to regularly review the remuneration policy and assess the performance of Directors and senior management[149]. - The Group has a zero-tolerance policy towards any form of sexual harassment and discrimination, with internal disciplinary actions for employees found in violation[176]. - The Group's commitment to diversity includes no discrimination based on gender, ethnic background, religion, or other prohibited grounds, enhancing its ability to address business issues[176]. - The Group recorded a significant increase in employee training hours, totaling 1,348 hours in the ESG Reporting Year, compared to 610 hours in 2020[189]. - The Group emphasizes compliance with labor protection laws, ensuring timely payment of wages, benefits, and insurance, with no reported labor disputes during the ESG Reporting Year[196]. Corporate Governance - The board of directors includes individuals with diverse backgrounds and expertise, contributing to effective decision-making and strategic planning[66]. - Mr. Wang Zhe has been appointed as an independent non-executive director since August 14, 2017, with extensive experience in the financial sector[72]. - Mr. Xu Liang Wei has over 20 years of experience in corporate administration and was appointed as an independent non-executive director on August 14, 2017[72]. - Mr. Chan Chi Keung has over 20 years of experience in auditing and financial management, appointed as an independent non-executive director on November 15, 2017[77]. - Ms. Yu Yixing, appointed as deputy general manager on November 1, 2019, has over 10 years of experience in financial investment[78]. - Mr. Ng Kam Ming has been appointed as the financial controller and company secretary since August 1, 2019, with over 10 years of experience in auditing and accounting[82]. - The company is focused on expanding its real estate development and management capabilities, leveraging the expertise of its executive team[65]. - The management team has a proven track record in the real estate sector, which is expected to drive future growth and market expansion[65]. - The company is committed to enhancing its operational efficiency and financial performance through strategic management practices[66]. - The leadership team is well-equipped to navigate the challenges of the real estate market, ensuring sustainable growth and profitability[66]. - The company aims to explore new opportunities in the real estate sector, supported by its experienced management team[65].

┣(3 保集健康控股有限公司 11-11-13 保集健康控股有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號：1246 202 INTERIM REPORT 中期報告 客格 会山 目錄 Contents 8 | --- | --- | |-------------------------------------------------------------------------------------|-------| | | | | 公司資料 CORPORATE INFORMATION | | | 簡明綜合損益及其他全面收益表 CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND | | | OTHER COMPREHENSIVE INCOME | | | 簡明綜合財務狀況表 CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION | | | 簡明綜合 ...